Related references
Note: Only part of the references are listed.An engineered superantigen SEC2 exhibits promising antitumor activity and low toxicity
Mingkai Xu et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2011)
Biological analysis of the deletion mutants of Staphylococcal enterotoxin C2
Xiaogang Wang et al.
APPLIED MICROBIOLOGY AND BIOTECHNOLOGY (2009)
Identification and Characterization of Two Novel Staphylococcal Enterotoxins, Types S and T
Hisaya K. Ono et al.
INFECTION AND IMMUNITY (2008)
A phase II study of a 5T4 oncofoetal antigen tumour-targeted superantigen (ABR-214936) therapy in patients with advanced renal cell carcinoma
D. M. Shaw et al.
BRITISH JOURNAL OF CANCER (2007)
Gene expression and function study of fusion immunotoxin anti-Her-2-scFv -: SEC2 in Escherichia coli
MK Xu et al.
APPLIED MICROBIOLOGY AND BIOTECHNOLOGY (2006)
Identification of a secondary zinc-binding site in staphylococcal enterotoxin C2 - Implications for superantigen recognition
AC Papageorgiou et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Identification of a new putative enterotoxin SEU encoded by the egc cluster of Staphylococcus aureus
C Letertre et al.
JOURNAL OF APPLIED MICROBIOLOGY (2003)
Superantigen-induced apoptotic death of tumor cells is mediated by cytotoxic lymphocytes, cytokines, and nitric oxide
TK Mondal et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2002)
Superantigens: microbial agents that corrupt immunity
M Llewelyn et al.
LANCET INFECTIOUS DISEASES (2002)
Superantigen bacterial toxins:: state of the art
H Müller-Alouf et al.
TOXICON (2001)
Exotoxins of Staphylococcus aureus
MM Dinges et al.
CLINICAL MICROBIOLOGY REVIEWS (2000)
Share Paper
